Search results for "cancer diagnosis"

The HALO Prostate AI algorithm is deployed in HALO AP® from Indica Labs

The identification of this genetic variant could help select lung cancer patients who may be at risk of more severe autoimmune side effects

The RACE act has led to increased requirements for approval of recent pediatric cancer drugs

The cell lines offer researchers a diverse cohort of patient specific models to accelerate drug development

356-patient concordance study confirms performance using head-to-head testing vs. droplet digital PCR

This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future

Companion diagnostic can help guide treatment decisions in cases of NSCLC

Mathematical models are used to analyse lymph node morphology and predict risk of cancer spread

High performance compact “workhorse” UV/Vis Spectrophotometer for the analytical laboratory. Ideal in a multiuser, multi-application laboratory and for users who require IQ/OQ validation Features Long life Xenon source On-board software for standard and life science applications plus method storage Built in self test diagnostics for GLP instrument performance validation 8 position sample changer as standard Optiona…

Your Fast and Reliable Slide Scanner for Brightfield and Fluorescence.

An affordable benchtop instrument for Sanger sequencing and fragment analysis.

Your High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

The ZEISS Axioscan 7 combines scanning performance with application freedom

The Somatom scanner is equipped with a forward-looking camera and motorized wheels, allowing a single technologist to navigate the device through hospital hallways

The Bio-Rad SARS-CoV-2 ddPCR Kit is a powerful diagnostic tool in the battle against COVID-19, with sensitivity and precision beyond that of qPCR assays.

Explore the world of epigenomics and its impact on cancer research in conversation with Dr. Jorg Tost and Prof. Martin Hirst